Kenney Richard T 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Jun 9, 2021
Insider Transaction Report
Form 4
Kenney Richard T
Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-06-09$1.54/sh+15,000$23,100→ 50,000 total
Footnotes (1)
- [F1]Includes unvested RSUs.